辛格龙作为对认知障碍的神经保护剂:临床前研究的系统审查
Tosin A Olasehinde1,2, Oyinlola O Olaokun3
1Nutrition and Toxicology Division, Food Technology Department, Federal Institute of Industrial Research, Oshodi, P.M.B. 21023, Lagos 100261, Nigeria.
International journal of molecular sciences
|July 12, 2025
概括
来自生的辛格龙在减少神经炎症和改善认知功能方面表现有前途. 这种天然化合物可以通过向关键炎症途径来帮助缓解焦虑和抑郁.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
背景情况:
- 认知障碍,包括学习缺陷和记忆功能障碍,是严重的健康问题.
- 神经炎症越来越多地被认为是焦虑和抑郁症的病原体的一个关键因素.
- 生是一种生物活性化合物,具有已知的抗氧化和抗炎性质.
研究的目的:
- 系统地审查现有的关于辛格龙对神经炎症影响的科学文献.
- 评估辛格龙对与记忆,学习,焦虑和抑郁有关的神经行为变化的影响.
主要方法:
- 在Google Scholar,Scopus和Web of Science中进行了系统的文献搜索.
- 九项研究符合数据提取和分析的纳入标准.
- 神经炎症标志物 (IL-1β,IL-6,TNF-α,IBA-1) 和行为测试 (莫里斯水迷宫,Y迷宫等) 进行了评估.
主要成果:
- 辛格龙通过降低IL-1β,IL-6和TNF-α水平,显示出显著的抗神经炎症作用.
- 在激活的微质细胞 (IBA-1) 水平上没有观察到显著的变化.
- 机制包括抑制NF-kB和NLRP3炎症酶激活,并减少nNOS.
结论:
- 辛格龙通过减轻神经炎症和氧化应激,表现出神经保护性质.
- 该化合物通过神经递质调节显示出抗焦虑和抗抑郁作用的潜力.
- 辛格龙的认知增强能力需要进一步研究治疗应用.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
212
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
212
Alzheimer's Disease: Treatment
263
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
263


